论文信息 - First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody–Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors - 字舞流文

First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody–Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors

J. Nemunaitis | J. Bendell | B. Childs | C. Elbi | H. Kindler | P. Rajagopalan | A. Santin | Anish Thomas | Stella K. Kim | N. Sarapa | G. Blumenschein | R. Hassan | A. Walter | S. Seward | D. Laurent | K. Moore